The 8th NRI-conference Monday May 6th to Wednesday 8th 2013
"Nordic health research and Innovation networks - conference"

Home NRI

Secher, David

Dr. and an independent consultant in the area of research commercialisation – in the UK and internationally. He is based in the University of Cambridge, UK. He is also a Life Fellow of Gonville and Caius College, Cambridge; and a director of PraxisUnico (the technology transfer professional association). In 2002, together with Lita Nelsen of MIT, he founded Praxis (now PraxisUnico), the leading

technology transfer training company. For his contributions to creating “environments that favour enterprise, specialising in the practical aspects of commercialising the results of academic research”, he received the Queen’s Award for Enterprise Promotion in 2007.

Other previous roles include Chief Executive of the N8 Research Partnership (a collaboration of the eight most research-intensive universities in the North of England); Director of Research Services, University of Cambridge; Director of Drug Development, Cancer Research Campaign (now Cancer Research UK); and Director of Monoclonal Therapeutics, Celltech Ltd. As a consultant, he has advised universities, governments and individuals on commercialisation of intellectual property, as well as acting as non-executive director of high technology and investment companies.

Secher graduated from the University of Cambridge (Churchill College) with first class honours in biochemistry. His PhD work at the Medical Research Council (MRC) Laboratory of Molecular Biology was with the late César Milstein (Nobel Prize-winner for discovery of monoclonal antibodies). Together with Derek Burke, Secher made and patented the first monoclonal antibody to human interferon.

Speaker on Monday May 7th 2012, Tutorial session Tuesday May 8th 2012

Last Updated ( Friday, 20 January 2012 )